Latent membrane protein 1: a key oncogene in EBV-related carcinogenesis?
Knecht
H
H
Department of Internal Medicine, CHUV University Hospital, Lausanne, Switzerland.
Brousset
P
P
Bachmann
E
E
Sandvej
K
K
Odermatt
B F
BF
D000956:Antigens, Viral / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D002051:Burkitt Lymphoma / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D017353:Gene Deletion; D015967:Gene Expression Regulation, Viral / Q000235:genetics / Q000276:immunology; D006566:Herpesviridae Infections / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D015394:Molecular Structure; D009857:Oncogenes / Q000235:genetics / Q000276:immunology; D014407:Tumor Cells, Cultured; D014412:Tumor Virus Infections / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D014763:Viral Matrix Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*
D000956:Antigens, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D014763:Viral Matrix Proteins